Navigation Links
IMPAX in Medical News

Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent

...Ltd. ("Mayne") have filed a second lawsuit against impax Laboratories, Inc. ("Impax") in the District Court...o the U.S. Food and Drug Administration ("FDA") by impax requesting approval to manufacture and sell a gene... in December 2008, the filing of a lawsuit against impax in response to Impax's submission of an ANDA reque...

Warner Chilcott Announces Receipt of FDA Response to Citizen Petition

...hat following the commencement of its anticipated infringement suit against impax Laboratories, Inc. ("Impax") it will be entitled to a 30-month stay of approval with respect to the impax ANDA for a generic version of DORYX 150 mg delayed-release tablets. D...

Warner Chilcott Announces Receipt of Paragraph IV Certification Notice

... received a Paragraph IV Certification Notice from impax Laboratories, Inc. ("Impax") advising that impax has filed an Abbreviated New Drug Application (AND...tail of the Paragraph IV Certification Notice from impax and intend to vigorously defend the 161 patent and...

Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent

...arner Chilcott previously announced the filing of similar lawsuits against each of Mutual Pharmaceutical Company, Inc., Mylan Pharmaceuticals Inc. and impax Laboratories, Inc. on December 23, 2008. The lawsuit is in response to the submission of an Abbreviated New Drug Application ("ANDAs") to the U....

Visage Imaging and Agfa Healthcare Sign Worldwide Agreement to Integrate Visage Offerings to the IMPAX(TM) Suites

...ative thin-client streaming technology. Because of the tight integration of impax and Visage CS, large 3D and 4D images become instantly accessible at the cl...ntage of the existing RIS/PACS infrastructure." Visage CS integrated into impax provides breathtaking performance for data access as well as for different ...
IMPAX in Medical Technology

Warner Chilcott Files Lawsuits for Infringement of DORYX(R) Patent

...ceutical Company, Inc. ("Mutual"), Mylan Pharmaceuticals Inc. ("Mylan") and impax Laboratories, Inc. ("Impax") in the District Court for the District of New... the U.S. Food and Drug Administration ("FDA") by each of Mutual, Mylan and impax requesting approval to manufacture and sell generic versions of DORYX 100 a...

IMPAX Presents at Movement Disorder Society's 11th International Congress of Parkinson's Disease and Movement Disorders

... HAYWARD, Calif.--(BUSINESS WIRE)--Jun 8, 2007 - impax Laboratories, Inc. (OTC:IPXL) today announced that...nosis and treatment of Movement Disorders. About impax Laboratories, Inc. impax Laboratories, Inc. is a technology based specialty...
IMPAX in Medical Products

IMPAX Cardiology

Description:... impax for Cardiology is the first digital solution designed specifically for card...sts and their customers to work the way they want, wherever they want. The impax for Cardiology network is the key to efficiency improvements. Users enjoy o...
Company:Agfa Healthcare
IMPAX in Biological Technology

Wyeth and Impax Announce Final Settlement of Effexor XR Patent Suit

-- Federal Court Enters Consent Judgment Terminating Litigation -- MADISON, N.J., July 16 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) and Impax Laboratories Inc. today announced that all conditions of a settlement of the U.S. patent infringement litigation pertaining to Impax's proposed g...

Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion

...ed a civil investigative demand requesting that it provide information to the FTC relating to its settlement with Barr and its earlier settlement with impax Laboratories, Inc. The Company is cooperating fully with this investigation and believes that the settlements are in compliance with all applicable la...

The Parkinson's Disease Foundation Commemorates its 50th Anniversary with Special Scientific Symposium on Parkinson's Disease

... UCB, Inc.; GlaxoSmithKline; Solvay Pharmaceuticals, Inc.; Carol and Melvin Taub and Family; Valeant Pharmaceuticals North America; The Avicena Group; impax Pharmaceuticals, Inc.; Medtronic, Inc.; the Medtronic Foundation; PatientsLikeMe, Inc.; Sepracor; Solstice Neurosciences, Inc.; Teva Neuroscience; Ver...
Other Tags
(Date:7/25/2014)... Florida Hospital and MOSI officially announced a transformational ... to come and make a difference in the Tampa Bay ... check to provide the support needed to keep the science ... transform the IMAX Dome Theatre from film to a state-of-the-art ... Dome Theatre in the state of Florida, and it is ...
(Date:7/25/2014)... -- The human brain can preserve oxygen to protect ... finds. Although dehydration significantly reduces blood flow ... the brain compensates by increasing the amount of oxygen ... helped us understand a lot more about how the ... study first author Steven Trangmar, a researcher at Brunel ...
(Date:7/25/2014)... 25, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Ibuprofen and Oxcarbazepine Tablets . ... lot of Ibuprofen and one lot of Oxcarbazepine Tablets, by ... mislabeled packaging. Oxcarbazepine is used for the treatment of certain ... The reason for the recall is that Lot #142588, Expiration ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 A new study ... revealed that 39 percent of all children in the survey ... , The survey looked at 2,505 children during the years of ... four years of age. The final result was that about ... care. Many of these children were from lower-income families and were ...
(Date:7/25/2014)... 25, 2014 A new study of participants ... which are published today in Cancer , found evidence ... 74 who had an abnormal finding on a lung cancer ... of life than did those who were screened and found ... surprise to the researchers. “We expected that participants with an ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 2Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 3Health News:Florida Hospital Donates a Two Million Dollar Transformational Gift to the Museum of Science and Industry (MOSI) 4Health News:Human Brain Has Coping Mechanism for Dehydration 2Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5
(Date:7/24/2014)... York, NY - July 24, 2014 -- Keryx Biopharmaceuticals, ... from the long-term, randomized, active control Phase 3 study ... iron-based phosphate binder, for the treatment of hyperphosphatemia in ... PERFECTED study (PhosphatE binding and iRon delivery with FErric ... Journal of the American Society of Nephrology ...
(Date:7/24/2014)... Bushmeat, the use of native animal species for food ... be a significant factor in the decline of many ... new study indicates that more than half of the ... raptors and hornbills., "By surveying not only the meat ... being eaten inside the forest by hunters and brought ...
(Date:7/24/2014)... study has identified two factors that characterize sustainable ... production of highly qualified physics teachers. Specifically, one ... physics teacher education in combination with institutional motivation ... viable. Science, Technology, Engineering and Math (STEM) teacher ... study points the way for institutions seeking to ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4Creating sustainable STEM teacher preparation programs 2
Other Contents